検索結果

で失明の主 な原因となっています 8。日本では、約 10 万人が罹患していると推定されており、これまでに承認された治療法はありません でした 2,3。 参考文献 1 Boyer DS, et al. The pathophysiology of geographic atrophy secondary to age-related macular degeneration and the comp...

Research and Development System | Research & Development | SENJU Pharmaceutica

through a flexible concept without adhering to a conventional framework or stereotypes. Looking at the future and quickly developing safe drugs that are needed are our goals as well as our wishes. Me...

Business Activities | About Senju | SENJU Pharmaceutical

Based on a sense of mission to contribute to the health of the eyes of people around the world, and a development policy that puts top priority on safety, we have always taken a pioneering path in oph...

Business Activities | About Senju | SENJU Pharmaceutical

Based on a sense of mission to contribute to the health of the eyes of people around the world, and a development policy that puts top priority on safety, we have always taken a pioneering path in oph...

Over-The-Counter Medicines | Business Activities | About Senju | SENJU Pharmaceutical

lence in ophthalmological drugs, Senju Pharmaceutical has cultivated expertise as a pioneer in over-the-counter preparations. Our OTC line of gentle and effective products includes a variety of specia...